Product Name
IGF-1R, Polyclonal Antibody
Full Product Name
Anti-IGF-1R (Ab-1161) Rabbit pAb
Product Synonym Names
IGFR; CD221; IGFIR; JTK13; kinase IGF1R; Insulin-like growth factor I receptor
Product Gene Name
anti-IGF-1R antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P08069
Species Reactivity
Human, Mouse, Rat
Purity/Purification
Affinity Purified
Form/Format
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration
1.0mg/mL (lot specific)
Immunogen
Peptide sequence around aa.1159~1163 (D-I-Y-E-T) derived from Human IGF-1R.
Sensitivity
The antibody detects endogenous level of total IGF-1R protein.
Other Notes
Small volumes of anti-IGF-1R antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-IGF-1R antibody
Entrez Summary: Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Product Categories/Family for anti-IGF-1R antibody
Receptors, Kinase/Phosphatases
Applications Tested/Suitable for anti-IGF-1R antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Application Notes for anti-IGF-1R antibody
WB: 1:500~1:1000
Western Blot (WB) of anti-IGF-1R antibody
Western blot analysis of extracts from 293 cells using IGF-1R (Ab-1161) Antibody and the same antibody preincubated with blocking peptide.

Immunofluorescence (IF) of anti-IGF-1R antibody
Immunofluorescence staining of methanol-fixed MCF cells using IGF-1R (Ab-1161) Antibody.

Immunohistochemistry (IHC) of anti-IGF-1R antibody
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using IGF-1R (Ab-1161) Antibody (left) or the same antibody preincubated with blocking peptide (right).

NCBI/Uniprot data below describe general gene information for IGF-1R. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000866.1
[Other Products]
NCBI GenBank Nucleotide #
NM_000875.3
[Other Products]
UniProt Primary Accession #
P08069
[Other Products]
UniProt Secondary Accession #
Q14CV2; Q9UCC0; B1B5Y2[Other Products]
UniProt Related Accession #
P08069[Other Products]
NCBI Official Full Name
insulin-like growth factor 1 receptor isoform 1
NCBI Official Synonym Full Names
insulin like growth factor 1 receptor
NCBI Official Symbol
IGF1R [Similar Products]
NCBI Official Synonym Symbols
IGFR; CD221; IGFIR; JTK13
[Similar Products]
NCBI Protein Information
insulin-like growth factor 1 receptor
UniProt Protein Name
Insulin-like growth factor 1 receptor
UniProt Synonym Protein Names
Insulin-like growth factor I receptor; IGF-I receptor
UniProt Gene Name
IGF1R [Similar Products]
UniProt Synonym Gene Names
IGF-I receptor [Similar Products]
NCBI Summary for IGF-1R
This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
UniProt Comments for IGF-1R
IGF1R: a receptor tyrosine kinase that binds insulin-like growth factor 1 (IGF1) with a high affinity and IGF2 with a lower affinity. Functions as an anti-apoptotic agent by enhancing cell survival. Can play a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. Tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains contribute to the formation of the ligand- binding domain, while the beta chain carries the kinase domain. Interacts with PIK3R1 and with the PTB/PID domains of IRS1 and SHC1 in vitro when autophosphorylated on tyrosine residues. Mutated in rare cases of pre- and post-natal growth retardation. One SNP associated with increased human longevity. Increased expression of IGF1R and other pathway members associated with progression and malignancy in a range of cancers. Inhibitors: AG1024, AEW541.
Protein type: EC 2.7.10.1; InsR family; Kinase, protein; Membrane protein, integral; Protein kinase, TK; Protein kinase, tyrosine (receptor); TK group
Chromosomal Location of Human Ortholog: 15q26.3
Cellular Component: integral to plasma membrane; intracellular membrane-bound organelle; membrane; plasma membrane; receptor complex
Molecular Function: identical protein binding; insulin binding; insulin receptor binding; insulin receptor substrate binding; insulin-like growth factor binding; insulin-like growth factor I binding; insulin-like growth factor receptor activity; phosphoinositide 3-kinase binding; protein binding; protein-tyrosine kinase activity
Biological Process: immune response; inactivation of MAPKK activity; insulin receptor signaling pathway; insulin-like growth factor receptor signaling pathway; negative regulation of apoptosis; phosphoinositide 3-kinase cascade; phosphoinositide-mediated signaling; positive regulation of cell migration; positive regulation of cell proliferation; positive regulation of DNA replication; protein amino acid autophosphorylation; protein tetramerization; regulation of JNK cascade; signal transduction
Disease: Insulin-like Growth Factor I, Resistance To
Research Articles on IGF-1R
1. Positive correlations indicated probable cross-talk between the IGF-IR-mediated and adiponectin-mediated signaling pathways.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.